Trials / Completed
CompletedNCT00569842
Investigation of the Cylex® ImmuKnow® Assay
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- Indiana University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Currently, there is no accurate way of predicting the occurrence of Graft vs Host Disease (GvHD) or infection. The purpose of this study is to analyze blood with the ImmuKnow® Assay to see if doctors can detect which patients are at risk for GvHD and for getting an infection before they occur.
Conditions
- Leukemia
- Non-Hodgkin's Lymphoma
- Chronic Lymphocytic Leukemia
- Hodgkin's Disease
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Aplastic Anemia
- Chronic Myelogenous Leukemia
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2010-02-01
- Completion
- 2012-12-01
- First posted
- 2007-12-07
- Last updated
- 2014-09-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00569842. Inclusion in this directory is not an endorsement.